Xencor (XNCR) Capital Expenditures Growth (3y) (2016 - 2026)
Xencor (XNCR) Capital Expenditures Growth (3y) (2016 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Capex Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,621.14 Bn | 66,620.85 Bn | - | - |
| 2 | Nanobiotix | 1,915.18 Bn | 1,915.11 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | - |
| 4 | BeOne Medicines | 471.27 Bn | 466.48 Bn | 1.35 Bn | -12.25% |
| 5 | Vertex Pharmaceuticals | 121.81 Bn | 114.57 Bn | 2.59 Bn | 46.88% |
| 6 | Regeneron Pharmaceuticals | 69.58 Bn | 60.82 Bn | 3.31 Bn | 8.97% |
| 7 | Belite Bio | 62.72 Bn | 62.72 Bn | - | - |
| 8 | Argenx Se | 55.51 Bn | 50.33 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.35 Bn | 37.35 Bn | - | - |
| 10 | Xencor | 1.49 Bn | 1.11 Bn | - | -61.61% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -61.61% |
| Dec 31, 2025 | -51.46% |
| Sep 30, 2025 | -76.49% |
| Jun 30, 2025 | -68.59% |
| Mar 31, 2025 | -11.58% |
| Dec 31, 2024 | -35.91% |
| Sep 30, 2024 | -22.56% |
| Jun 30, 2024 | 9.85% |
| Mar 31, 2024 | -59.25% |
| Dec 31, 2023 | -32.23% |
| Sep 30, 2023 | -15.51% |
| Jun 30, 2023 | 83.66% |
| Mar 31, 2023 | 73.27% |
| Dec 31, 2022 | 50.73% |
| Sep 30, 2022 | 76.17% |
| Jun 30, 2022 | 104.15% |
| Mar 31, 2022 | 71.38% |
| Dec 31, 2021 | 31.38% |
| Sep 30, 2021 | 39.60% |
| Jun 30, 2021 | 28.74% |